Medical Research
Antibiotic Resistance Issues
LHHS Appropriations
H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13
H.Con. Res. 85 S. 369, H.R. 1706- Patent Settlements
S. 515 Patent Reform Act of 2009
S. 610 Patent Reform Act of 2009
H.R. 1260 Patent Reform Act of 2009 Senate and House comprehensive health reform bills
FDA regulations affecting MRSA products; FDA HAth-Waxman and patent issues; Comparative Effectiveness research; ARRA; Patent Regorm S. 515, H.R. 1260; Follow-on Biologics H.R. 1427 H.R. 1548
s. 525, H.R. 1298- drug reimportation H.R. 3200- health care reform
H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs
H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs
Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)
Anti-couterfeiting legislation concerning drugs (pedigree)
S. 301 Physicians Payments Sunshine Act of 2009
Medical Research
Antibiotic Resistance issues
Kennedy American Affordable Health Choices Act of 2009
H.R. 3200 American Affordable Health Choices Act of 2009
Tri Caucus Healthcare Reform Bill 
Baucus/Finance Healthcare Reform Bill - Amerca's Healthy Future Act of 2009
S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009
H.R. 2400 Strategies to Address Antimicorbial Resistance Act (STARR)
H.R. 2937 MRSA Infection Prevention and Patient Protection Act
H.R. 2502 Comparative Effectiveness Research Act of 2009
S. 1213 Patient-Centered Outcomes Research Act of 2009 Medicare In-Patient Hospital Payment Procedures
Medicare coverage issues
H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009
S. 254 Medicare Home INfusion Therapy Coverage Act of 2009 S. 301 Physicians Payments Sunshine Act of 2009
Kennedy American Affordable Health Choices Act of 2009
H.R. 3200 American Affordable Health Choices Act of 2009
Tri Caucus Healthcare Reform Bill
Baucus/Finance Healthcare Reform Bill - America's Healthy Future Act of 2009
S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009
H.R. 2502 Comparative Effectiveness Research Act of 2009
S. 1213 Patient-Centered Outcomes Research Act of 2009 Medical Research 
Prescription Drug/Federal Drug Admin/Center for Disease Control/Health and Human Services Issues
Antibiotic Resistance Issues
H.R. 2400 Strategies to Address Antimicrobial Resistance Act (STAAR) H.R 2937 MRSA Infection Prevention and Patient Protection Act
S. 269 Preserve Access to Affordable Generics Act of 2009
BUD - Budget/Appropriations CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid PHA - Pharmacy
134 - Centers For Disease Control & Prevention (CDC) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 134 - Centers For Disease Control & Prevention (CDC) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 134 - Centers For Disease Control & Prevention (CDC) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 134 - Centers For Disease Control & Prevention (CDC) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 134 - Centers For Disease Control & Prevention (CDC) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CUBIST PHARMACEUTICALS, INC.
65 Hayden Avenue, Lexington, MA, 02421, US
MARK THOMAS BATTAGLINI (Mike Enzi, Sr. Senator WY, Congressional Fellow) MARK THOMAS BATTAGLINI (Mike Enzi, Sr. Senator WY, Congressional Fellow) MARK THOMAS BATTAGLINI (Mike Enzi, Sr. Senator WY, Congressional Fellow) MARK THOMAS BATTAGLINI (Mike Enzi, Sr. Senator WY, Congressional Fellow) MARK THOMAS BATTAGLINI (Mike Enzi, Sr. Senator WY, Congressional Fellow)
Mike Enzi, Sr. Senator WY, Congressional Fellow Mike Enzi, Sr. Senator WY, Congressional Fellow Mike Enzi, Sr. Senator WY, Congressional Fellow Mike Enzi, Sr. Senator WY, Congressional Fellow Mike Enzi, Sr. Senator WY, Congressional Fellow